-
Progress in Stem Cell Science & Regenerative Medicine On Tap in Los Angeles, 26-29 June
Top scientists and researchers from academia, medicine, and industry will gather to share groundbreaking stem cell science and its translation to clinical application at the annual meeting of the International Society for Stem Cell Research (ISSCR), 26-29 June in Los Angeles, Calif.Full story -
Advocating for Science and Research
Scientists play a critical role in advocating for research that is advancing healthcare and biomedicine. In the February edition of Stem Cell Reports, several ISSCR researchers share their answers to the question 'Why is it important to you to support fetal tissue research?'Full story -
ISSCR Announces 2019 Award Recipients
The ISSCR announces the recipients of its 2019 Award for Innovation, Dr. Susan Lim Award for Outstanding Young Investigator, Tobias Award Lecture, and Public Service Award. Awardees will be recognized at the ISSCR annual meeting, 26-29 June, in Los Angeles, Calif., U.S.Full story -
New Voices, Breakthrough Science at ISSCR 2019
If you’re an enterprising stem cell scientist with exciting work to publish this year, the ISSCR annual meeting in Los Angeles, 26-29 June, is the place to take the stage and showcase your science to colleagues and the field. We’ve developed a new program structure this year that dedicates 15 plenary speaking spots to abstract-selected speakers, to showcase the talents of the next generation of scientists.Full story -
ISSCR Introduces Chief Operating Officer Keith Alm
Keith Alm joined the ISSCR as chief operating officer in January 2019, after serving as a brand strategist and consultant for the society for nearly a decade. He’s worked with many of the organization's leaders on strategic positioning, communications, and partnerships.Full story -
Standing Up for Scientific Research
The ISSCR’s support for stem cell science and the field is central to our mission, and we speak up for policies around the world that allow our work to continue and thrive. We also provide background and current understanding about stem cell science to inform decision makers about key issues affecting science and health.Full story -
ISSCR Testimony in U.S. Congress Regarding Need for Fetal Tissue Research
In written and oral testimony before the U.S. House of Representatives Oversight and Government Reform Committee today, former ISSCR president Sally Temple describes fetal tissue research as essential in studying and developing therapies for cancer, HIV, Zika, tuberculous, and other devastating diseases.Full story -
2018 ISSCR Year in Review
Stem cell science and regenerative medicine has made great progress in 2018, with significant clinical trials underway in several research areas, and advances in understanding that are illuminating new research pathways. The role of the ISSCR in supporting the research and its responsible translation to the clinic has never been more important. I want to highlight for you some of ISSCR’s work throughout the year that I believe helps advance science, give voice to our members, and sustain this ever-evolving field.Full story -
ISSCR Comments on Reports of Chinese Scientists Performing Genome-Editing During Fertility Treatment
Reports indicate that scientists in China have used CRISPR-mediated genome editing during in vitro fertilization to modify the genetic material of two embryos that were subsequently implanted into a patient, leading to the birth of two babies. As ISSCR and a number of other organizations have previously stated, the use of nuclear genome editing technologies, such as CRISPR, during fertility treatment is premature and should not be attempted at this time.Full story -
ISSCR Comments to FDA Regarding ClinicalTrials.gov
In a letter to the U.S. Food and Drug Administration (FDA), the ISSCR commented on proposed industry guidance for "Civil Money Penalties Relating to the ClinicalTrials.gov Data Bank."Full story -
ISSCR Applauds FDA, FTC for Holding Deceptive Stem Cell Clinics Accountable
The U.S. Food and Drug Administration has issued a warning letter to StemGenex of San Diego after an investigation found its cellular therapy does not conform with good manufacturing practice requirements, is being illegally marketed to treat conditions for which it has not been proven safe or effective, and is putting patients at risk.Full story -
New Perspectives in Stem Cell Reports
In this month's issue of the ISSCR journal, 2018 award recipients Graziella Pellegrini and Michele De Luca (Innovation Award), and Connie Eaves (Tobias Lecture), share perspectives on their science, and scientists write about the ethical challenges of premature delivery of stem cell-based therapies.Full story -
Convergence of Stem Cell Science and Medicine
Stem cell research is moving ever more deliberately toward the clinic with increasing momentum and is recognized as one of the most promising approaches for developing new kinds of medicines. The rapid advances in this field are having profound effects on how researchers conceive and pursue their work in traditional academic or research institutions and in commercial enterprises.Full story -
ISSCR Letter to U.S. Department of Transportation re Transportation of Animals for Research
The ISSCR writes in support of the National Association for Biomedical Research (NABR) complaint requesting relief from discriminatory airline carriage policies that impede the transportation of animals for biomedical research.Full story -
Developing Trainees, Expanding Horizons
I take seriously my responsibility to support and nurture future generations of stem cell scientists. Indeed, it is critical for all of us in this evolving field to help trainees and others coming up in the field, to ensure they have opportunities to learn, grow, make connections, and share their science.Full story -
ISSCR Comments on Horizon Europe
The ISSCR has responded to the European Commission proposal and the European Parliament's amendments for Horizon Europe, the seven-year research and innovation funding program to follow Horizon 2020.Full story -
ISSCR Voice is Heard on Capitol Hill
In mid-September, the U.S. Senate debated and passed a spending bill that included an increase in funding for the Department of Health and Human Services but did not include a ban on federal funding for fetal tissue research. ISSCR treasurer Arnold Kriegstein visited Senate and House leaders and staff on Capitol Hill shortly after the vote to voice appreciation for the Senate effort.Full story -
ISSCR Responds to U.S. Department of Health and Human Services Decision Regarding Fetal Tissue Research
The ISSCR is troubled by the HHS decision to “conduct a comprehensive review of all fetal tissue research.” The directive appears to come after intensive lobbying efforts by special interest groups with the goals of delaying or curtailing scientific research that relies on fetal tissue.Full story -
ISSCR Journal Focuses on Women in Stem Cell Science; Reflections by CEO Nancy Witty
The ISSCR has always had strong female leaders, and many of them are featured in the September and October editions of Stem Cell Reports.Full story -
Energizing for Renewed Focus
Many of us find time in the summer to reflect on work and recharge our batteries. Vacations, visits with friends, and time with family all help get away from everyday concerns in the lab and gain some perspective to inform the scientific path for the year ahead.Full story -
Nominate for ISSCR Awards and Leadership Positions
The ISSCR is soliciting nominations to honor exceptional and innovative research and support for young scientists, through its extensive awards program. It also invites members to nominate candidates to serve on the ISSCR board of directors.Full story -
2018 ISSCR Annual Meeting Wrap-up
The ISSCR 2018 Annual Meeting went “down under” to Melbourne, Australia where 3,000 stem cell scientists, clinicians, and professionals from 52 countries gathered to share their latest research, network with colleagues, and explore the latest technologies driving the field forward.Full story -
Douglas A. Melton Becomes President of the ISSCR
The ISSCR is pleased to announce Douglas A. Melton, PhD, Harvard University, as the incoming president of the ISSCR and its board of directors. Melton assumed the post on 23 June, 2018, immediately following the 16th ISSCR Annual Meeting in Melbourne, Australia.Full story -
ISSCR Announces New Editor-in-chief for Stem Cell Reports Journal
The ISSCR has appointed Martin F. Pera, professor at the Jackson Laboratory, U.S., as the next editor-in-chief of Stem Cell Reports, the organization’s open-access journal. Pera will succeed Christine Mummery, who led the journal since its launch in 2013. Pera will assume the post in January, 2019.Full story -
ISSCR Opposes Proposal to Restrict Fetal Tissue Research
The ISSCR opposes the U.S. House of Representatives proposal to ban federal funding for fetal tissue research. ISSCR President Hans Clevers released a statement on the issue.Full story -
ISSCR Announces Hamburg, Germany as Site of 2021 Annual Meeting
The ISSCR will hold its 2021 annual meeting in Hamburg, Germany, the first time the organization will be meeting in that city. The meeting is expected to draw 4,000 stem cell researchers and professionals from around the globe to the Congress Center Hamburg, scheduled to open in 2019. The meeting will be held 23-26 June, 2021.Full story -
ISSCR Responds to President Trump Signing 'Right to Try' Law
The ISSCR is disappointed with the enactment of the ‘Right to Try’ law. Along with more than 100 patient and research groups opposing the bill, we believe it will put patients at risk and undermine the effective FDA Expanded Access Program already in place to give seriously ill patients access to experimental treatments.Full story -
ISSCR Applauds Federal Injunctions Against Stem Cell Clinics
The ISSCR is pleased that federal prosecutors in the U.S. have taken action to halt the marketing and delivery of unproven stem cell treatments at clinics they allege are operating outside of FDA regulation.Full story -
Active Support for Stem Cell Research Around the World
Scientific progress requires that legislators and regulators around the world recognize and appreciate the value of research and actively support pro-science policies. The ISSCR, through its policy program, champions the advancement of stem cell research and its translation to medicine.Full story -
ISSCR 2018 to Highlight Research Driving New Discoveries and Advances in Regenerative Medicine
Progress in stem cell research and its translation to medicine is the focus of the International Society for Stem Cell Research annual meeting 20-23 June at the Melbourne Convention & Exhibition Centre in Melbourne, Australia.Full story -
ISSCR Applauds Australia’s Move to Regulate Autologous Human Cell and Tissue Products
The ISSCR appreciates the new framework proposed by Australia’s Therapeutic Goods Administration (TGA) for the regulation of human cell and tissue products that use a person’s own cells (‘autologous use’).Full story -
ISSCR Advocates for Stem Cells and Basic Research in Europe
ISSCR members and staff met 12 April with the European Parliament’s Committee on Industry, Research and Energy to advocate for investments in basic research in the European Union’s 9th Framework Programme for Research and Innovation.Full story -
Collaborations for Improving Human Health
Like many stem cell researchers, my work is increasingly focused on developing ways to translate basic scientific discovery into treatments that help people suffering from disease or injury. The potential for stem cell therapies initially fascinated me as a developmental biologist, and over time I’ve learned the very real impact that our science can have on human health.Full story -
ISSCR Advocates for Science Investment in Letter to European Commission
In a letter to the European Commission today, the ISSCR encourages the EU to spur innovation by supporting basic research and programs that foster cooperation among fundamental research endeavors across Europe.Full story -
Media Registration Open for ISSCR 2018 20-23 June, Melbourne, AUS
Credentialed reporters can register and attend the 2018 annual meeting in Melbourne, Australia. They will have access to the many stem cell researchers and clinicians from around the world who will be discussing recent findings and progress that is driving development of stem cell treatments and cures for disease.Full story -
ISSCR Announces Recipients of 2018 Awards
Recipients of the 2018 awards will be presented at the society’s annual meeting, 20-23 June in Melbourne, Australia: ISSCR Award for Innovation, Dr. Susan Lim Award for Outstanding Young Investigator, Tobias Award Lecture, and Public Service Award.Full story -
'Right to Try' Legislation in U.S. House of Representatives is Narrowly Defeated; ISSCR Opposed
The legislation would have put patients at risk, slowed the development of effective stem cell therapies, and blocked the Food and Drug Administration (FDA) from access to crucial data about the safety and effectiveness of new medical treatments.Full story -
ISSCR 2018 Election Results
The ISSCR is pleased to announce the results of its 2018 leadership election. On behalf of all members, we extend congratulations to newly-elected officers and board members.Full story -
Scientific Excellence at ISSCR 2018
Scientific excellence is at the core of the ISSCR and is reflected each year in the annual meeting, where exceptional science is shared, discussed, and deliberated. This exchange is key to advancing the scientific dialogue that moves the field forward. The 2018 program in Melbourne, Australia continues that tradition, featuring groundbreaking research presented in plenary, concurrent, and poster sessions.Full story -
ISSCR Releases Guidebook to Evaluate Cell Therapy Trials
The ISSCR is pleased to announce the release of “Stem Cell Based Clinical Trials: Practical Advice for Physicians and Ethics / Institutional Review Boards,“ a guidebook providing background and fundamental questions for clinicians and review boards to ask when considering running or reviewing early phase, cell-based clinical trials. The guide was developed by practicing physician-scientists and stem cell professionals on the ISSCR’s Clinical Translation Committee.Full story -
Showcasing Inspiring Science and Natural Beauty
There is no better host city for the ISSCR 2018 annual meeting than Melbourne, Australia, a global hub of innovation in science and biotech with a rich stem cell history, flourishing research culture, and inspiring natural beauty and art.Full story -
Stem Cell Reports Seeking Editor-in-Chief
The ISSCR’s official journal, Stem Cell Reports, is seeking applications for a new Editor-in-Chief to succeed Christine Mummery, who has served in that role since the journal's inception in 2012.Full story -
ISSCR Members Asked to Vote for Future Leaders
The election is open for several ISSCR leadership posts, and members and trainee members are eligible to cast ballots in the election. Voting closes 5 February, 2018.Full story -
ISSCR 2018: Stem Cells Down Under
Stem cell research has led to profound insights into how developmental processes work in plants, animals, and humans. Increasingly, our work has shed light on how different life forms begin, develop, mature, and respond to injury and age. Myriad advances continue to contribute to understanding biology, cell function, disease and its treatment, senescence, and end of life.Full story -
ISSCR Announces Two New Science Communications & Education Managers
The ISSCR has selected Christopher Barry, PhD, and Julie Perlin, PhD, to be Science Communications & Education Managers, beginning 3 January, 2018.Full story -
ISSCR Remembers Hiromitsu “Hiro” Ogawa
The ISSCR is saddened by the passing of Hiromitsu “Hiro” Ogawa, a generous and thoughtful man who was a great supporter of stem cell science and the ISSCR.Full story -
ISSCR Announces New Policy Director, Eric Anthony
The ISSCR has named Eric Anthony to be its new Director of Policy. Anthony served more than eight years as staff in the U.S. Congress, most recently as legislative director for Congresswoman Rosa DeLauro of Connecticut. He will join the Society in early January 2018.Full story
Media Contact
